
Research on Drug Traceability System Based on Blockchain Technology
- 1 Changzhou Institute of Technology
- 2 Beijing Jiaotong University
- 3 Sichuan University of Science and Engineering
* Author to whom correspondence should be addressed.
Abstract
Because of the frequent occurrence of drug safety incidents in recent years, drug safety cannot be effectively guaranteed. The purpose of this study is to establish a blockchain-based drug traceability system and strengthen the construction of a drug information technology traceability system. Because the traditional drug traceability system depends on a certain center, there are many traceability participants, and the information is difficult to integrate, resulting in incomplete and unreliable traceability information. The use of blockchain technology can achieve data tamper-proof and decentralization so that each drug can be tracked through the unique identifier on the blockchain to ensure the integrity and authenticity of the data. Finally, "one thing, one code, one traceability code" will be realized, to strengthen the sharing of traceability information, realize the traceability of the whole variety and process, and improve drug safety. The drug traceability system consists of the data collection system, product traceability identification system, data statistical analysis system, and other subsystems. The platform uses distributed ledgers, blockchain, data technology, smart contracts, data mining and analysis, and other technologies to achieve multiple functional requirements such as anti-counterfeiting traceability of enterprise products, process tracking, data statistics, and so on.
Keywords
drug traceability system, blockchain technology, decentralization, drug safety, multiple functional requirements
[1]. Uddin, M. (2021) Blockchain medledger: a hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry. International Journal of Pharmaceutics, 597(x), 120235.
[2]. Musamih, A., Salah, K., Jayaraman, R., Arshad, J., & Ellahham, S. (2021) A blockchain-based approach for drug traceability in healthcare supply chain. IEEE Access, PP(99).
[3]. Ding, W., & Yang, Y. (2020) The construction of drug traceability system based on block chain technology. Asia Society Medicine.
[4]. Sabah, S., Hasan, A. S. M. T. , & Daria, A. (2022) A blockchain-based approach todetect counterfeit drugs inmedical supply chain.
[5]. Kumari, K., & Saini, K. (2020) Data handling & drug traceability: blockchain meets healthcare to combat counterfeit drugs. (3).
[6]. Uddin, M., Salah, K., Jayaraman, R., Pesic, S., & Ellahham, S. (2021) Blockchain for drug traceability: architectures and open challenges: Health Informatics Journal, 27(2), 4571-4579.
[7]. Nofer, M., Gomber, P., Hinz, O. et al. Blockchain. Bus Inf Syst Eng 59, 183–187 (2017).
[8]. Guosheng Lin, Chunhua Shen, Qinfeng Shi, Anton van den Hengel, David Suter, Fast Supervised Hashing with Decision Trees for High-Dimensional Data, Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition (CVPR), 2014, pp. 1963-1970
[9]. Ittai Abraham, Shelly Grossman, SBFT: A Scalable and Decentralized Trust Infrastructure, IEEE, 2019 Harish Sukhwani, José M. Martínez, Performance Modeling of PBFT Consensus Process for Permissioned Blockchain Network (Hyperledger Fabric), IEEE, 2017
[10]. Harish Sukhwani, José M. Martínez, Performance Modeling of PBFT Consensus Process for Permissioned Blockchain Network (Hyperledger Fabric), IEEE, 2017
Cite this article
Zhu,C.;Chen,R.;Zhu,Y. (2023). Research on Drug Traceability System Based on Blockchain Technology. Applied and Computational Engineering,8,302-310.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 2023 International Conference on Software Engineering and Machine Learning
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).